Clinical trial
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
NCT03297775 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 22, 2017
- Completion date
- June 30, 2027
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
interstitial lung disease, rheumatoid arthritis